# European Journal of Ophthalmology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/european-journal-of-ophthalmology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 86,317 |
| h-index | 83 |
| Homepage | https://us.sagepub.com/en-us/nam/european-journal-of-ophthalmology/journal203448 |
| Open Access | false |
| ISSN-L | 1120-6721 |
| ISSNs | 1120-6721,1724-6016 |
| OpenAlex ID | https://openalex.org/S128637052 |
| Publisher | SAGE Publishing |
| Works | 7,218 |

## Journal papers

Showing 12 of 22.

- [Dry Eye Syndrome-Related Quality of Life in Glaucoma Patients](https://scholariq.org/papers/dry-eye-syndrome-related-quality-of-life-in-glaucoma-patients/)
- [Do Adherence Rates and Glaucomatous Visual Field Progression Correlate?](https://scholariq.org/papers/do-adherence-rates-and-glaucomatous-visual-field-progression-correlate/)
- [Cataract surgery and dry eye disease: A review](https://scholariq.org/papers/cataract-surgery-and-dry-eye-disease-a-review/)
- [Bevacizumab-Augmented Retinal Laser Photocoagulation in Proliferative Diabetic Retinopathy: A Randomized Double-Masked Clinical Trial](https://scholariq.org/papers/bevacizumab-augmented-retinal-laser-photocoagulation-in-proliferative-diabetic/)
- [Risk Factors to Develop Ocular Surface Disease in Treated Glaucoma or Ocular Hypertension Patients](https://scholariq.org/papers/risk-factors-to-develop-ocular-surface-disease-in-treated-glaucoma-or-ocular/)
- [The Effect of Chronic Ischemia on the Primate Optic Nerve](https://scholariq.org/papers/the-effect-of-chronic-ischemia-on-the-primate-optic-nerve/)
- [Intravitreal Bevacizumab versus Combined Bevacizumab-Triamcinolone versus Macular Laser Photocoagulation in Diabetic Macular Edema](https://scholariq.org/papers/intravitreal-bevacizumab-versus-combined-bevacizumab-triamcinolone-versus/)
- [Shotgun metagenomic sequencing in culture negative microbial keratitis](https://scholariq.org/papers/shotgun-metagenomic-sequencing-in-culture-negative-microbial-keratitis/)
- [A 1-Year Study to Compare the Efficacy and Safety of Once-Daily Travoprost 0.004%/Timolol 0.5% to Once-Daily Latanoprost 0.005%/Timolol 0.5% in Patients with Open-Angle Glaucoma or Ocular Hypertension](https://scholariq.org/papers/a-1-year-study-to-compare-the-efficacy-and-safety-of-once-daily-travoprost-0-004/)
- [Intraocular lens power calculation formula accuracy: Comparison of 12 formulas for a trifocal hydrophilic intraocular lens](https://scholariq.org/papers/intraocular-lens-power-calculation-formula-accuracy-comparison-of-12-formulas/)
- [Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures](https://scholariq.org/papers/ranibizumab-prefilled-syringes-benefits-of-reduced-syringe-preparation-times-and/)
- [Scleral fixation of Carlevale intraocular lens: A new tool in correcting aphakia with no capsular support](https://scholariq.org/papers/scleral-fixation-of-carlevale-intraocular-lens-a-new-tool-in-correcting-aphakia/)

## Journal top topics

Showing 8 of 25.

- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal and Macular Surgery](https://scholariq.org/topics/retinal-and-macular-surgery/)
- [Intraocular Surgery and Lenses](https://scholariq.org/topics/intraocular-surgery-and-lenses/)
- [Corneal surgery and disorders](https://scholariq.org/topics/corneal-surgery-and-disorders/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)
- [Ocular Surface and Contact Lens](https://scholariq.org/topics/ocular-surface-and-contact-lens/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.